RNU6ATAC9P

Across TCGA pan-cancer cohorts, RNU6ATAC9P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6ATAC9P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6ATAC9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6ATAC9P expression acts as an unfavorable survival marker, although some lineages such as LUAD and HNSC show a favorable association.

THCA, LUAD, and BLCA are the cancer types where RNU6ATAC9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.967	0.993	<.001	75	view →
LUAD	OS	Tertile	III,IV	0.867	0.570	<.001	60	view →
BLCA	OS	Tertile	IV	0.096	0.590	<.001	42	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	40	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
KICH	OS	Tertile	II,III,IV	0.155	0.880	<.001	27	view →
READ	DFS	Tertile	IV	0.055	0.646	<.001	27	view →
ESCA	OS	Quartile	All	0.358	1.000	.009	24	view →
HNSC	DFS	Tertile	All	0.429	0.337	.026	21	view →
CHOL	OS	Tertile	All	0.238	0.673	.042	18	view →
KIRP	DFS	Tertile	All	0.738	0.929	.002	18	view →
COAD	DFS	Tertile	III,IV	0.214	0.555	.014	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6ATAC9P–THCA (OS)

Open the THCA breakdown →